CdS/BiOBr heterojunction photocatalyst with high performance for solar-light-driven degradation of ciprofloxacin and norfloxacin antibiotics

Sunlight active CdS/BiOBr heterojunction photocatalyst was fabricated by a solvothermal route. To the best of our knowledge, the novelty of the research is based on the decoration of the hexagonal CdS nanoparticles on the surface of the tetragonal BiOBr microflowers for the creation of a heterostructure photocatalyst used for the removal of the antibiotics. The CdS/BiOBr-1:3 heterojunction exhibited 100% removal of norfloxacin and ciprofloxacin under simulated visible light. In addition, complete degradation of the antibiotics under natural sunlight was also achieved. Construction of the CdS/BiOBr heterojunction is a promising strategy for the improvement of photocatalytic performance due to a decrease in the charge carrier recombination rate at the interface, an increase in the visible light absorption range, and an enhancement of the surface area of the resultant product. The removal of the pollutants fit very well with the first-order reaction. The photogenerated hole played a crucial role in the removal of the antibiotics. Confirmation of the stability of the CdS/BiOBr heterojunction was also elucidated. The photoactivity of the photocatalyst remained the same after the fifth cycle implying the excellent cycling ability of the sample. This research demonstrates the promising potential of the CdS/BiOBr heterojunction for degradation of toxic antibiotics presented in water.

Automated summary

The CdS/BiOBr heterojunction photocatalyst was fabricated using a solvothermal route, showing excellent photocatalytic activity for the removal of antibiotics. The research demonstrated the promising potential of the CdS/BiOBr heterojunction for degrading toxic antibiotics in water, with stable photocatalytic performance after multiple cycles.